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Seizure diaryAn epilepsy community was developed on PatientsLikeMe.com to share data between patients to improve
their outcomes by ﬁnding other patients like them. In a 14-day response period, 221 patients with epilepsy
(mean age: 40 years, SD: 12, range: 17–72, 66% female) completed a survey about beneﬁts they perceived.
Prior to using the site, a third of respondents (30%) did not know anyone else with epilepsy with whom
they could talk; of these, 63% now had at least one other patient with whom they could connect. Perceived
beneﬁts included: ﬁnding another patient experiencing the same symptoms (59%), gaining a better under-
standing of seizures (58%), and learning more about symptoms or treatments (55%). Number of beneﬁts
was associated with number of relationships with other patients, F(4,216)=8.173, Pb0.001). Patients with
epilepsy reported an array of perceived beneﬁts similar to those reported by populations with other diseases.
Controlled sharing of health data may have the potential to improve disease self-management of people with
epilepsy.
© 2011 Elsevier Inc. Open access under CC BY-NC-ND license. 1. Introduction
Patients diagnosed with epilepsy face a number of challenges.
Their disease is complex, and even those treated at specialty clinics
are not well informed about their condition [1]. Stigma is common
and can have severe consequences [2] caused by patients’ perceived
“otherness” [3]. Interventions tend to focus on educating the general
population to alter their attitudes and beliefs [4]. Another approach is
empowering people with chronic illness by harnessing the Internet to
create a community of similar people to share experiences and sup-
port one another.
The Internet has a number of useful features for social support [5]
and enables “ridiculously easy group formation” [6]. Although the use
of online communities in epilepsy is not new [7], recent develop-
ments include increasing uptake of high-speed Internet access, the
ready availability of “Web 2.0” applications [8], mobile access, and
the e-patient movement (e.g., www.e-patients.net [9]). In 2008 it
was estimated that around 60% of patients with epilepsy in the United
States had access to the Internet [10].Street, Cambridge, MA, 02141.
ks).
-ND license. Epilepsy-speciﬁc sites such as PatientsLikeMe.com, Epilepsy.com,
and SeizureTracker.com may provide patients with a number of ben-
eﬁts that have been recognized as important in permitting patients to
live well with their epilepsy [11]. First, they may improve knowledge
of their disease via high-quality content. Second, the social support
can improve patients’ self-management through a number of mecha-
nisms such as improved self-efﬁcacy, positive social norms, and
reduction of stigma [12]. Third, helping patients track their disease
through online seizure diaries avoids backﬁlling [13] and creates the
potential to record additional, valid details to share with health care
professionals. Mobile applications even allow a third party (e.g., a
parent) to video-record the seizure for later review.
In studies, individual online educational interventions such as
WebEase have produced beneﬁts in epilepsy self management, med-
ication adherence, sleep quality, self-efﬁcacy, and social support
[14], and this system will be made widely available later in 2011
[15]. Bergin et al. [16] proposed that an open, multicenter online sys-
tem with data entered by clinicians (recently realized as EpiNet [17])
would help clinical management, comparative effectiveness research,
and trial recruitment.
Outside epilepsy, online communities have been found to improve
the quality of patient–physician interactions [18] and improve patients’
emotional well-being, perceived disease control, empowerment, medi-
cal literacy [19], and ability to cope [20]. Patients with stigmatizing
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port, ﬁnding health information and communicating with a physician
online [21,22]. Although such beneﬁts may not accrue to those who
still do not have Internet access, through a “collateral health” effect,
even patients who have not directly participated in an online service
may still beneﬁt [23].
PatientsLikeMe.com is a patient-centered online platform [24].
Brieﬂy, the site allows patients with life-changing illnesses to share
their medical data with other patients “like them” by longitudinally
charting patient-reported outcomes, symptoms, side effects, medical
history, and treatments. Because data are collected in a structured
format (e.g., symptoms are coded in MedDRA, treatments are sup-
ported by the Multum database, with patient-entered data curated
by health care professionals), they can be aggregated to form interac-
tive reports that reﬂect real-life trends [25], and patient reported out-
comes may even serve to identify treatment effects [26].
Launched in January 2010, new platform features speciﬁc to epi-
lepsy were developed with funding provided by UCB. We developed
a “seizure meter” (Figs. 1 and 2) that allows patients to record the
type, frequency, and severity of their seizures on a weekly basis. In
addition, there are a number of epilepsy-speciﬁc questions asked of
users who complete their condition history, including driving status,
family history, pregnancy, and diagnostic tests. Epilepsy-speciﬁc
treatments such as antiepileptic drugs, surgical options, and dietary
interventions were pre-programmed into the system, and adverse
events detected from patients taking the sponsor's (UCB's) medica-
tions are submitted to the manufacturer's drug safety department
for safety reporting.
Finally, we developed an epilepsy-speciﬁc research platform to
conduct a longitudinal research project with widely used patient-
reported outcome (PRO) measures consisting of the Quality of Life
Inventory in Epilepsy (QOLIE-31/P) [27], Hospital Anxiety and
Depression Scale (HADS) [28], and EQ-5D [29]. These data are in theFig. 1. Data entry in the Seizure Meter allows patients to report the frequprocess of being collected longitudinally, with interim analyses pre-
sented as the study progresses [30]. Participants in the PRO project
are shownwhere they stand in relation to other members of the com-
munity using physical, mental, and social summary scores derived
from the QOLIE-31/P (Fig. 3), with the intention of improving their
awareness of factors inﬂuencing their QOL, such as depressive symp-
toms, social support, and stigma [31]. All of these data are shared
openly with all other members of the community, allowing users to
search for one another on any of the medical variables captured
(e.g., epilepsy type, seizure type, treatments).
A previous study identiﬁed a number of perceived beneﬁts (e.g.,
better communication with health care professionals, learning about
symptoms, improved understanding of treatments and side effects)
arising from use of PatientsLikeMe among patients with amyotrophic
lateral sclerosis (ALS), multiple sclerosis (MS), Parkinson's disease,
human immunodeﬁciency virus (HIV), ﬁbromyalgia, and mood disor-
ders [24]. The purpose of this study was to gather feedback on per-
ceived beneﬁts from use of our online service by people with epilepsy.
In addition to the generic perceived beneﬁts identiﬁed in other
conditions we also anticipated epilepsy-speciﬁc beneﬁts. On the
basis of the stigma involved in epilepsy we hypothesized that, prior
to using the site, many patients with epilepsy would be relatively iso-
lated and have few social face-to-face relationships with other pa-
tients with epilepsy, but that an online community had the potential
to improve this situation. Further, we hypothesized that those who
participated most with other “patients like them” in the site and
formed strong ties with others would perceive greater beneﬁts than
those who did not.
2. Methods
An online survey was used to ﬁeld a set of epilepsy-speciﬁc ques-
tions relating to site usage, as well as generic questions replicatingency and severity of all seizures experienced in the previous week.
Fig. 2. A Seizure Meter for a patient with epilepsy. Larger circles represent a higher frequency of seizures; darker colors represent a higher perceived severity of seizures.
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ﬁdence in sharing health data and how that might have changed
through use of the site; quality of care (reported separately [32]);
treatment history; medication adherence; decision support around
treatments or symptoms; social support; epilepsy self-management;
and demographics. Our questionnaire is presented in supplementary
material (see Appendix). At the time of data collection the communi-
ty was accessible only to members in the United States; since April
2011 it is now open internationally. On September 15, 2010, invita-
tions were sent to 2362 patients with epilepsy who had been mem-
bers for at least 30 days, regardless of their level of log-in activity.
The invitation was sent as a private message within the Patients-
LikeMe community. Sampled patients had their own password-
protected log-in. They could complete the survey only once; weFig. 3. QOLIE-31/P summary scores of a patient with epilepsy inhave tools to prevent multiple accounts originating from the same
location. The survey was not mandatory to complete to continue
using the site. No incentives were offered; the total number of ques-
tions varied slightly by participants’ own responses to ﬁlter questions.
A reminder message was sent within a week to those who had not
yet completed the survey. The survey remained open for a period of
14 days. Only data from completed questionnaires are presented
here. As speciﬁed in the terms of use, members of PatientsLikeMe
join the site with the expectation that they will be participating in
research. As a service evaluation project with no anticipated adverse
consequences for participation, institutional review board approval
was not sought for this project. The recruitment message was sent
from P.W., who can easily be contacted by potential participants,
and can be viewed in supplementary material (see Appendix).context with other members of the epilepsy community.
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the 25 potential perceived beneﬁts listed in Tables 1 and 2 (range:
0–20). We excluded perceived beneﬁts (indicated by footnote a) like-
ly to be tautological (i.e., positively scoring “Locating another person
who helped you understand what it is like to take a speciﬁc medica-
tion for your condition” would bias toward an association with site
participation) or those that might not be universally regarded as a
beneﬁt (e.g., changing physician). A single point was given if patients
endorsed any of the following categories: “Very helpful,” “Moderately
helpful,” “Strongly agree,” and “Agree.” No points were assigned for
other responses including “Does not apply.”
Data analysis was performed by P.W. using Statistics Package for
the Social Sciences (SPSS Version 18.0). Association between categor-
ical variables was assessed using the χ2 test; normally distributed
demographic data were compared using Student's t test (two groups)
or between-group ANOVA (three or more groups). Where overall
between-group differences on ANOVA were signiﬁcant, post hoc
t tests with Bonferroni correction were applied to test for paired com-
parisons. Nonparametric between-group differences were tested
using the Kruskal–Wallis test. Correlations were performed using
Pearson's r. Tests performed were two-tailed with α set at Pb0.05.
3. Results
Invitations to participate were sent to 2362 patients with epilepsy.
According to Web logs, at the time of analysis 348 members (15% of
those invited) logged in and opened the private message invitation.
Of these, 282 patients (81% of users logging in during this period,
12% of total) started the survey, and of these, 221 (64% of users log-
ging in, 9% of total) completed all questions. Sixty-one patients (18%
of users logging in, 3% of total) gave only partial responses and
were excluded from this analysis. Twenty-one patients (6% of users
logging in, 1% of total) opted out of the survey. To test for response
bias we compared the demographic characteristics of responders
against those of nonresponders. Responders were a little older than
nonresponders (mean age: 40 years (SD 12) for responders vs
36 years (SD 12) for nonresponders, F(3,1871)=8.259, Pb0.001)
and, accordingly, had experienced seizures longer (mean duration
since ﬁrst seizure: 23 years (SD 15) for responders vs 19 years (SD
14) for nonresponders, F(3,1806)=5.757, Pb0.001). Unsurprisingly,Table 1
Comparison of site beneﬁts reported by patients with epilepsy (Epilepsy, N=221) with th
(All, N=1322).
Source. Wicks et al., 2010 [24].
Decisions to change the medication used to treat your condition
Decisions about whether to change the dose of a medication for your condition
Decisions about whether to start using a medication for your condition
Understanding possible side effects of a medication for your condition
Locating another person who helped you understand what it is like to take a speciﬁc
medication for your conditiona
Decisions to stop using a medication for your condition
How helpful has recording your symptoms been to help you manage your condition?
How helpful have symptom ratings on your proﬁle been in understanding how your
treatments are working?
How helpful has PLM been in learning about a symptom or symptoms you experienced?
a Excluded from the beneﬁt count. N/A=Does not apply/Never tried to use for this.responders had logged in to the site more times since joining than
nonresponders (median log-ins: 15 (range 2–802) for responders vs
3 (range 0–548) for nonresponders, U=58648.5, Pb0.001). Most
nonresponders (66%) had not logged into the site since the survey in-
vitation was sent. Responders were no different from nonresponders
with respect to sex or epilepsy type (P>0.05).
Mean participant age was 40 years (SD: 12); two-thirds were fe-
male, 84% Caucasian. The largest proportions of respondents (44%)
had at least some college education and were married (40%); most
were not working for pay (53%). About half of the respondents had
a partial epilepsy syndrome, with one-third reporting a generalized
syndrome and 16% unknown. The most frequently reported syn-
drome was temporal lobe epilepsy (32%), followed by unspeciﬁed
syndrome (15%), grand mal seizures on awakening (10%), other par-
tial syndromes (8%), and juvenile myoclonic epilepsy (6%). About half
the respondents had been seizure free in the preceding 7 days, but
about one in ﬁve had had more than ﬁve seizures in the same period.
Mean disease duration was 23 years (SD: 15) since ﬁrst seizure and
19 years (SD: 14) since diagnosis. The largest proportion of respon-
dents were on polytherapy (≥2 AEDs, 60%); commonly used AEDs in-
cluded levetiracetam (both immediate release and extended release,
n=86, 39%), lamotrogine (n=60, 27%), topiramate (n=37, 17%),
and carbamazepine (n=36, 16%). Most respondents reported that
they were treated regularly by a neurologist (70%), and only 20% by
an epileptologist.
Table 1 lists items that were asked both of people with epilepsy
who used the website and, separately as part of a previous study,
of other PatientsLikeMe communities including those with MS
(N=347), Parkinson's disease (N=287), ALS (N=218), ﬁbromyalgia
(N=150), HIV (N=177), and mood disorders (N=144) [24]. The
most highly endorsed beneﬁts were for features of the site that
support self-management, such as learning about symptoms (51%
“very” or “moderately” helpful), understanding possible side effects
of medication (47%), and recording symptoms (45%).
Comparison of the two studies yielded similar results. For instance,
25% of patients with epilepsy rated the site as “very” or “moderately”
helpful in decisions to change medication, relative to 27% of patients
from the other communities. Where signiﬁcant differences were
found, these seemed to be accounted for by the fact that patients with
epilepsy were more likely not to have tried a particular site featureose reported by patients with MS, Parkinson's, ALS, ﬁbromyalgia, and mood disorders
How helpful has PLM been in...? χ2(4) P
Very
helpful
Moderately
helpful
A little
helpful
Not at all
helpful
N/A
Epilepsy 12% 13% 11% 7% 56% 4.265 0.371
All 13% 15% 10% 11% 52%
Epilepsy 11% 10% 13% 9% 58% 7.425 0.115
All 11% 15% 10% 12% 53%
Epilepsy 17% 10% 14% 6% 53% 18.098 0.001
All 20% 17% 10% 10% 43%
Epilepsy 27% 20% 15% 4% 34% 13.427 0.009
All 36% 22% 13% 6% 25%
Epilepsy 22% 18% 15% 5% 39% 9.883 0.042
All 29% 13% 12% 8% 38%
Epilepsy 14% 5% 10% 10% 62% 14.205 0.007
All 10% 12% 10% 12% 56%
Epilepsy 28% 17% 18% 9% 29% 40.781 b0.001
All 36% 23% 20% 8% 12%
Epilepsy 26% 17% 22% 6% 29% 29.330 b0.001
All 30% 25% 21% 8% 15%
Epilepsy 34% 21% 17% 5% 23% 35.475 b0.001
All 48% 24% 14% 4% 10%
Table 2
Reported beneﬁts of the site for epilepsy management issues (N=221).
How helpful has PatientsLikeMe (PLM) been in the following? Very helpful Moderately helpful A little helpful Not at all helpful N/A
How helpful has recording your seizures been to help you manage your condition? 28% 17% 20% 8% 26%
How helpful has PLM been in learning about seizures you experienced? 34% 21% 18% 7% 20%
To what extent do you agree with each of the following? Strongly agree Agree Disagree Strongly disagree N/A
PLM has helped me take medications more regularly. 10% 17% 11% 1% 60%
PLM has helped me ﬁnd ways to reduce treatment side effects. 8% 19% 15% 3% 56%
PLM has helped me ﬁnd another person who has the same symptoms.a 24% 35% 8% 2% 31%
I have received better care from my health care professional by recording symptoms on PLM. 10% 20% 10% 5% 55%
Using PLM gives me more and better control over my condition. 15% 35% 10% 4% 36%
As a result of using the site, my quality of life is better. 10% 35% 12% 6% 37%
As a result of PLM, I have changed my physician.a 5% 5% 16% 19% 54%
My health care team is supportive of my use of PLM.a 10% 15% 5% 5% 66%
Because of PatientsLikeMe … Strongly agree Agree Disagree Strongly disagree N/A
I have a better understanding of the type of seizures that I have. 22% 36% 9% 4% 29%
I have insisted on seeing a specialist to treat my seizures. 8% 9% 19% 5% 60%
I have had fewer visits to the ER caused by my seizures. 9% 9% 15% 7% 60%
I know how to ensure I get the AED that my doctor prescribed for me. 10% 18% 13% 5% 55%
I have gained greater control over my seizures. 8% 21% 16% 9% 46%
I have had access to information that helped identify the best AED for me. a 12% 27% 13% 5% 42%
a Excluded from the beneﬁt count. N/A=Does not apply/Never tried to use for this.
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recent launch of the community or some characteristics of epilepsy
compared with other diseases. For example, stopping a medication
completely would be less likely than in some other conditions. In sup-
port of the former hypothesis, the proportion of “does not apply” re-
sponses was negatively correlated with number of days on the site
(r=−0.162, P=0.016) and number of logins (r=−0.186, P=0.005).
Table 2 summarizes responses to epilepsy-speciﬁc questions
regarding the utility of the site; highly rated beneﬁts included learn-
ing about seizures (55% “very” or “moderately” helpful), ﬁnding an-
other person with the same symptoms (59% agreed), and recording
seizures to help manage the condition (45% helpful). Some beneﬁts
occurred less frequently but would presumably have a greater impact
on a patient's self-management. Thirty percent agreed they received
better care from health care professionals from recording symptoms
on PatientsLikeMe, 27% agreed that their medication compliance
improved because of the site, 27% reported reduced side effects, 18%
agreed they had fewer emergency room visits, and 17% reported
that, because of the site, they had insisted on seeing an epilepsy
specialist.
Participants were asked how closely they had followed directions
on when and how to take their drugs in the past 30 days. Most
patients (70%, N=154) reported being adherent all of the time; 27%
(N=60) reported “most of the time,” with only 2% (N=5) reporting
“about half of the time”; 0.5% (N=1) reported “some of the time”;
and 0.5% (N=1) were “never adherent.” Improved adherence as a
result of using the site was reported by 27% (N=60) of users, of
whom 75% (N=45) reported they had been adherent “all of theTable 3
Reported beneﬁt score by number of friends with epilepsy on PatientsLikeMe.
Number of friends on PatientsLikeMe
None 1 or 2 3 or 4
N
%
70
32%
62
28%
36
16%
Mean beneﬁt score
(SD)
4.6
(5.7)
6.3
(5.5)
8.7
(5.7)
Median beneﬁt score
(IQR)
2
(7)
5
(9)
9
(8)time” in the past 30 days. In an open text response one patient
wrote “In the past I had never really followed the advice or been
instructed on how this can affect you. But after seeing some readers
post the importance of taking your meds regularly (same time of
day consistently) it has really helped me stay on top of things.”
Another beneﬁt reported by patients was help in reducing treat-
ment side effects (endorsed by 27%, N=58). Another patient wrote:
“In looking for similar side effects with other patients I noticed a
trend on PatientsLikeMe. By collecting this data and discussing it
with my neurologist we were able to come up with a more satisfacto-
ry combination of meds over the next 6 months.”
Participants were asked how many people with epilepsy they
knew in both “the real world” and on PatientsLikeMe with whom
they would feel comfortable discussing information or opinions
about epilepsy. Prior to joining PatientsLikeMe, 30% (N=67) of re-
spondents knew nobody with epilepsy with whom they could talk;
63% (N=42) of these users now had at least one person on Patients-
LikeMe with whom they could talk about epilepsy.
Across all respondents, a mean of seven beneﬁts from use of the
site were perceived (SD: 6.2, median: 6, range: 0–20). Table 3 and
Fig. 4 show the distribution of the number of perceived beneﬁts by
number of close relationships with other patients in the system.
Post hoc Bonferroni tests revealed that patients with no close rela-
tionships to other patients on the system perceived signiﬁcantly
fewer beneﬁts (mean difference [95% CI]) from using the site than pa-
tients who had three or four friends (−4 [−8 to −0.6], P=0.08), 5
to 9 friends (−5 [−10 to −0.8], P=0.006), or ≥10 friends (−6
[−9 to −2], Pb0.001).Statistical test
5–9 ≥10
19
9%
34
15%
9.8
(2.8)
10.5
(6.8)
ANOVA:
F(4,216)=8.173
Pb0.001
9
(7)
11
(13)
Kruskal–Wallis: χ2(4)=30.159
Pb0.001
Fig. 4. Means plot showing the relationship between mean total number of perceived
beneﬁts (circle, whiskers represent 95% conﬁdence intervals) and number of friends
on PatientsLikeMe. Post hoc comparisons between groups (using Bonferroni-
corrected t tests) were signiﬁcant (Pb0.001) for differences between “none” and all
other categories.
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Patients with epilepsy reported an array of perceived beneﬁts
from using PatientsLikeMe. Users gained a better understanding of
their seizures (58%), learned more about a symptom or treatment
(55%), felt greater control over their condition (50%), had reduced
side effects (27%), improved adherence (27%), and had insisted on
seeing a specialist (17%) or, in some cases, even changed their physi-
cian (10%). Perhaps as a result of these perceived beneﬁts, 45% of
users agreed that using the site had improved their quality of life. Rel-
ative to other disease populations on PatientsLikeMe [24], the epilep-
sy community had not yet used all of the features available to them,
though this might be expected to change over time.
Themost prominent beneﬁts to be reported by users with epilepsy
included features that were intentionally designed into the site, such
as disease tracking (seizures and symptoms) and practical advice on
disease management (minimizing side effects). Although there are
no custom features on PatientsLikeMe to encourage medication ad-
herence or changes in health care provider, the social community
allowed users to identify problems and share solutions, presumably
via social tools and viewing each other's proﬁles. It is feasible that
adding additional functionality to support these goals could increase
the proportion of patients experiencing beneﬁts.
The Internet provides opportunity for patients to ﬁnd and connect
with other patients like them. About a third of our respondents (30%)
did not know anyone with epilepsy with whom they could talk about
their condition; of these, 63% found at least one person with epilepsy
with whom they could connect on PatientsLikeMe. The number of
beneﬁts perceived was associated with the number of relationships
that patients had with other patients in the system. Options for com-
munication on the site include open discussion in the forum, private
message exchange, or leaving comments on each other's proﬁles
[33]. Many of the beneﬁts identiﬁed relied on learning from the expe-
rience of others; presumably the more opportunities to learn from
others, the easier this would be to achieve. Future research could
identify tools to better connect patients within a peer group of opti-
mal size and composition.
The concept of online tools for tracking epilepsy is not new, as
evidenced by systems including Epilepsy.com, SeizureTracker.com,
EpiTrax, and a number of academic research projects. However,
although these systems allow patients with epilepsy to share theirinformation with their doctors, they do not permit sharing with
other patients, nor aggregation of structured data. For example, in a
traditional message board it might be possible for users to start a
thread about medication dosage or to write their medication regime
as a “signature” at the end of each message. On PatientsLikeMe, treat-
ment data on antiepileptic drugs are collected in a structured format
and dosages are displayed as a histogram; for instance, the treatment
report on levetiracetam shows dosages entered by 750 patients
with epilepsy (http://www.patientslikeme.com/treatments/show/3700-
levetiracetam). These structured, aggregated data reﬂect a larger sample
collected in a more systematic way than patients using the Internet
could access previously and might enhance their understanding of
how typical their dosage might be.
Clearly, giving patients more access to data is not entirely without
risk. Public interactions between patients are moderated by profes-
sional staff to ensure that users adhere to a code of conduct. For ex-
ample, “Ideal PatientsLikeMe Members share personal experiences
without trying to provide medical advice.” Fortunately the vast ma-
jority of users understand that changes to medication need to be dis-
cussed with their physician. To date, we have not identiﬁed any
reports of medical harm arising from interactions between patients;
this is an area that requires renewed attention in the literature [34].
However there is also the question of how prepared health care pro-
fessionals may be for the change in information balance brought by
the Internet [35,36], and we did identify a single case where a pa-
tient–provider relationship broke down, in part, because a patient in-
creased his or her health literacy. The female patient wrote in the
forum that her physician “complains … that I had (all of a) sudden
showed up for (appointments) knowing the proper medical terms
for things—that I ‘was using terms like pre-ictal’ and the like.… [The
physician] could no longer deal with me because, get this: I ‘had got-
ten with a bunch of people on the Internet’ and that they were now
‘advising’ my treatment/care!”
We agree with Bergin that “not … all epilepsy research should be
conducted in the manner we have outlined here … a double-blind
randomized controlled trial is the optimal way of comparing two or
more alternative treatments” [16]. However, there may be an oppor-
tunity to develop hybrid models where clinicians provide diagnostic
validation and objective measures and patients use seizure-tracking
tools, patient reported outcomes, adherence monitoring tools, and so-
cial networks in parallel. This has the potential to make more efﬁcient
use of physician time by highlighting issues in need of attention,
improving patient adherence to medical advice, and giving patients
psychosocial support. Some patients may be self-experimenting
with diet, exercise, or even pharmaceutical treatments, and a stan-
dardized data collection tool has the potential to help identify any
potential beneﬁts at the individual or even group level [26].
Many of the limitations to this study are shared by all online stud-
ies, including but not limited to: participation rates, biases, accuracy
of data collection, and variations in care systems. An important limi-
tation is that we lack independent veriﬁcation that site members
are really patients with epilepsy. Future research directions could in-
clude collaborations with specialty clinics to recruit veriﬁed patients.
The beneﬁts identiﬁed are perceived beneﬁts reported only by those
patients who chose to participate in the survey, though the fact that
these users represent 64% of all users who logged in during this peri-
od suggests these results are at least representative of regular site
users. Future work should use objectively collected data such as hos-
pital admissions andmedication reﬁlls. The overall response rate (9%)
was lower than in other communities [24], with response rates rang-
ing from 14 to 29% (mean: 19%). This can be explained by a low num-
ber of log-ins for most of the invited sample. Of the invited patients
who logged in to the site during the response window, 64% complet-
ed the survey. We also left the survey open for completion for a peri-
od of 14 days, which may have been too short for some patients to
participate; however, typically we receive 80% of responses to
22 P. Wicks et al. / Epilepsy & Behavior 23 (2012) 16–23surveys in the ﬁrst 2 days after launch and have not found lengthen-
ing the recruitment window to substantially improve completion
rates. An alternative approach to future work might be for a “service
evaluation” survey to be triggered by a given number of site log-ins;
this might ensure a more representative sample of respondents
than a cross-sectional approach.
Previous research has shown that the PatientsLikeMe epilepsy
population is more likely to be female, to have more patients in
their twenties to forties, and to have more patients on polytherapy
than patients with epilepsy in a health insurance claims database
[37]. Our sample is broadly similar to that of the online study of pa-
tients with epilepsy of Escoffery et al., whose sample was 57% female
and 88% Caucasian, but was a little younger (mean age 38 years) and
more likely to have had at least some college education [10]. Escoffery
et al. identiﬁed a number of demographic differences between online
samples and their clinic samples; a larger proportion of whites were
online, with a lower level of disability and higher levels of education
[10]. A clear limitation to the Internet more broadly is the “informa-
tion divide” that inevitably arises between those who are computer-
literate and those who are not [38]. This may be particularly true of
veteran populations, where only half of patients are reported to
have access to the Internet [39]. It is likely that our users represent
early adopters of health technology, but it is hoped that barriers to ac-
cess will be reduced in the future. There may be additional unmea-
sured biases in the nature of patients who return to the website or
completed our survey. Although PatientsLikeMe is a for-proﬁt compa-
ny and funded in part by industry, we attempt to be transparent with
our members (a link on the front page of the website leads readers to
a section on “How We Make Money”), and we use the platform to
conduct research for industry, not as an advertising platform.
Patients with epilepsy evaluated a data-sharing website as having
beneﬁts in supporting their self-management; such technology may
be more easily scaled than traditional real-world support groups
andmay be of value to providers and nonproﬁts in improving the out-
comes of their patients. Future research should be conducted using
traditional interventional methodologies, for example, a randomized
trial of a “prescription” for patients to use PatientsLikeMe versus
other types of websites such as static epilepsy information (e.g.,
WebMD) or a community that allows qualitative discussion but not
data sharing (e.g., Braintalk), with objectively captured outcome data.
5. Conclusion
An online community that is structured like PatientsLikeMe encour-
ages patients to share and learn fromdata that are potentiallymore sys-
tematic than in previous efforts. Sharing of health data through the use
of seizure-tracking tools, medication records, and other opportunities
for patient self-report that are dynamically linked and referenced in on-
line discussionmay have the potential to improve disease management
and health outcomes of peoplewith epilepsy through improved disease
knowledge and self-management. Further work is needed to yield im-
portant clinical beneﬁts such as improved seizure control, reduced
emergency room visits, and improved medication adherence through
online tools for people with epilepsy.
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